International Consensus on Use of Continuous Glucose Monitoring

Cited by (1,003)

Items 301–400 of 1,003

1. COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way
   Thomas Danne, Catarina Limbert · 2020 · The Lancet Diabetes & Endocrinology
2. Robust Determination of the Optimal Continuous Glucose Monitoring Length of Intervention to Evaluate Long-Term Glycemic Control
   Pau Herrero, Antonia Alalitei, Monika Reddy, Pantelis Georgiou, Nick S. Oliver · 2020 · Diabetes Technology & Therapeutics
3. Glycemic Variability, Oxidative Stress, and Impact on Complications Related to Type 2 Diabetes Mellitus
   Tatiana Valente, Alberto Krayyem Arbex · 2020 · Current Diabetes Reviews
4. Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts
   Tamara K. Oser, Michelle L. Litchman, Nancy A. Allen, Bethany M. Kwan, Lawrence Fisher, Bonnie T. Jortberg, William H. Polonsky, Sean M. Oser · 2021 · Current Diabetes Reports
5. “I was ready for it at the beginning”: parent experiences with early introduction of continuous glucose monitoring following their child's type 1 diabetes diagnosis
   Tanenbaum, Molly L., Zaharieva, Dessi P., Addala, Ananta, Ngo, Jessica, Prahalad, Priya, Leverenz, Brianna, New, Christin, Maahs, David M., Hood, Korey K. · 2021 · Diabetic Medicine
6. The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set
   Beck, Roy W., Bergenstal, Richard M., Riddlesworth, Tonya D., Kollman, Craig · 2019 · Diabetes Technology & Therapeutics
7. Development and Validation of a Machine Learning Model to Predict Weekly Risk of Hypoglycemia in Patients with Type 1 Diabetes Based on Continuous Glucose Monitoring
   Simon Lebech Cichosz, Morten Hasselstrøm Jensen, Søren Schou Olesen · 2024 · Diabetes Technology & Therapeutics
8. Efficacy of the Diabeloop closed‐loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise
   Hélène P. Hanaire, Sylvia Franc, Sophie Borot, Alfred Penfornis, Pierre‐Yves Benhamou, Pauline Schaepelynck, Éric Renard, Bruno Guerci, N. Jeandidier, C. Simon et al. · 2019 · Diabetes Obesity and Metabolism
9. Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo‐RESOLVE) project
   Bastiaan E. de Galan, Rory J. McCrimmon, Mark R. Ibberson, Simon R. Heller, Pratik Choudhary, Frans Pouwer, Jane Speight, Jill Carlton, Thomas Rudolf Pieber, Myriam Rosilio et al. · 2020 · Diabetic Medicine
10. Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring
    Michelle Diane Lundholm, Mary Ann Emanuele, Alina Ashraf, Sarah Nadeem · 2020 · Journal of Diabetes and its Complications
11. RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
    Rajeev Chawla, S. V. Madhu, B. M. Makkar, Sujoy Kumar Ghosh, Banshi Saboo, Sanjay Kalra, On behalf of RSSDI-ESI Consensus Group · 2020 · International Journal of Diabetes in Developing Countries
12. The Impact of Physical Activity on Glycemic Variability Assessed by Continuous Glucose Monitoring in Patients With Type 2 Diabetes Mellitus: A Systematic Review
    Sebastian L. Bennetsen, Camilla S. Feineis, Grit Elster Legaard, Mark P. P. Lyngbæk, Kristian Karstoft, Mathias Ried‐Larsen · 2020 · Frontiers in Endocrinology
13. A retrospective in‐depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management
    Fabian Peeks, Irene J. Hoogeveen, R. Lude Feldbrugge, Rob Burghard, Foekje de Boer, Marieke J. Fokkert‐Wilts, Melanie M. van der Klauw, Maaike H. Oosterveer, Terry G. J. Derks · 2021 · Journal of Inherited Metabolic Disease
14. Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes
    Eslam Montaser, Chiara Fabris, Boris P. Kovatchev · 2022 · Diabetes Technology & Therapeutics
15. Continuous Glucose Monitoring Reveals Perioperative Hypoglycemia in Most Patients With Diabetes Undergoing Major Surgery
    Christian Jakob Carlsson, Kirsten Nørgaard, Anne‐Britt Oxbøll, Mette I.V. Søgaard, Michael Patrick Achiam, Lars Nannestad Jørgensen, Jonas Eiberg, Henrik Palm, Helge B. D. Sørensen, Christian Sylvest Meyhoff et al. · 2021 · Annals of Surgery
16. Continuous glucose monitoring devices: A brief presentation (Review)
    Doina Andrada Mihai, Simona Ștefan, Daniela Stegaru, Elena Georgiana Bernea, Ileana Adela Văcăroiu, Toma Marius Papacocea, Mircea Ovidiu Denis Lupușoru, Adriana Elena Nica, Ovidiu Ştiru, Dorin Dragoș et al. · 2021 · Experimental and Therapeutic Medicine
17. Continuous glucose monitoring-derived glycemic metrics and adverse pregnancy outcomes among women with gestational diabetes: a prospective cohort study
    Xinxiu Liang, Yuanqing Fu, Sha Lu, Menglei Shuai, Zelei Miao, Wanglong Gou, Luqi Shen, Yuhui Liang, Fengzhe Xu, Yunyi Tian et al. · 2023 · The Lancet Regional Health - Western Pacific
18. OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody–Positive Individuals
    Alyssa Ylescupidez, Cate Speake, Susan L. Pietropaolo, Darrell M. Wilson, Andrea K. Steck, Jennifer L. Sherr, Jason L. Gaglia, Christine Bender, Sandra M. Lord, Carla J. Greenbaum · 2023 · The Journal of Clinical Endocrinology & Metabolism
19. Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia
    Ana María Gómez, Diana Cristina Henao, Angélica Imitola Madero, Lucía B. Taboada, Viviana Cruz, María Alejandra Robledo Gómez, Martín Rondón, Óscar Múñoz, G. Maira, Fabian Mauricio León Vargas · 2019 · Diabetes Technology & Therapeutics
20. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices—The Maastricht Study
    Yuri D. Foreman, Martijn C.G.J. Brouwers, Carla Kallen, Demi M. E. Pagen, Marleen M. J. van Greevenbroek, Ronald M.A. Henry, Annemarie Koster, Anke Wesselius, Nicolaas C. Schaper, Coen D.A. Stehouwer · 2019 · Diabetes Technology & Therapeutics
21. Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report
    Alessandro Rossi, Erasmo Miele, Simona Fecarotta, Maria Veiga‐da‐Cunha, Massimo Martinelli, Carmine Mollica, Maria Rosaria D'Armiento, Enza Mozzillo, Pietro Strisciuglio, Terry G. J. Derks et al. · 2021 · The Italian Journal of Pediatrics/Italian journal of pediatrics
22. Ensemble Models of Cutting-Edge Deep Neural Networks for Blood Glucose Prediction in Patients with Diabetes
    Félix Tena, Óscar Garnica, Juan Lanchares, José Ignacio Hidalgo · 2021 · Sensors
23. In‐home use of a hybrid closed loop achieves time‐in‐range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial
    Thekla von dem Berge, K Remus, Sarah Biester, Felix Reschke, Britta Klusmeier, Kerstin Adolph, Anette Holtdirk, Andreas Thomas, Olga Kordonouri, Thomas Danne et al. · 2022 · Diabetes Obesity and Metabolism
24. Time in range: How to measure it, how to report it, and its practical application in clinical decision-making
    Wright, Eugene E., Morgan, Kayla, Fu, Danny K., Wilkins, Nick, Guffey, William J. · 2020 · Clinical Diabetes
25. Real-time continuous glucose monitoring in adolescents and young adults with type 2 diabetes can improve quality of life
    Chesser, Hannah, Srinivasan, Shylaja, Puckett, Cassidy, Gitelman, Stephen E., Wong, Jenise C. · 2024 · Journal of Diabetes Science and Technology
26. Rate of post-bariatric hypoglycemia using continuous glucose monitoring: A meta-analysis of literature studies
    Roberta Lupoli, Erminia Lembo, Carmen Rainone, Luigi Schiavo, Antonio Iannelli, Matteo Nicola Dario Di Minno, Brunella Capaldo · 2021 · Nutrition Metabolism and Cardiovascular Diseases
27. Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE
    Richard M. Bergenstal, ELISE HACHMANN-NIELSEN, Kajsa Kvist, Anne L. Peters, Jens M. Tarp, John B. Buse · 2023 · Diabetes Technology & Therapeutics
28. Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study
    Claudia Anita Piona, Marco Marigliano, Chiara Roncarà, Enza Mozzillo, Francesca Di Candia, Angela Zanfardino, Dario Iafusco, Giulio Maltoni, Stefano Zucchini, Elvira Piccinno et al. · 2023 · Diabetes Technology & Therapeutics
29. Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All
    Priya Prahalad, Ananta Addala, Bruce A. Buckingham, Darrell M. Wilson, David M. Maahs · 2018 · Diabetes Technology & Therapeutics
30. Comparison of Continuous Glucose Monitoring Accuracy Between Abdominal and Upper Arm Insertion Sites
    Isabelle Isa Kristin Steineck, Zeinab Mahmoudi, Ajenthen Gayathri Ranjan, Signe Schmidt, John Bagterp Jørgensen, Kirsten Nørgaard · 2019 · Diabetes Technology & Therapeutics
31. Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor
    Sanchez, Patricia, Ghosh-Dastidar, Samanwoy, Tweden, Katherine S., Kaufman, Francine R. · 2019 · Diabetes Technology & Therapeutics
32. Fuzzy model-based controller for blood glucose control in type 1 diabetes: An LMI approach
    Bahareh Farahmand, Maryam Dehghani, Navid Vafamand · 2019 · Biomedical Signal Processing and Control
33. Glycemic control in the critically ill: Less is more
    Ghaith Alhatemi, Haider Aldiwani, Rafal Alhatemi, Marwah Hussein, Suzan Mahdai, Berhane Seyoum · 2022 · Cleveland Clinic Journal of Medicine
34. Time With Diabetes Distress and Glycemia-Specific Distress: New Patient-Reported Outcome Measures for the Psychosocial Burden of Diabetes Using Ecological Momentary Assessment in an Observational Study
    Dominic Ehrmann, ANDREAS J. SCHMITT, Lilli Priesterroth, Bernhard Kulzer, Thomas Haak, Norbert Hermanns · 2022 · Diabetes Care
35. Bihormonal Artificial Pancreas With Closed-Loop Glucose Control vs Current Diabetes Care After Total Pancreatectomy
    Charlotte L. van Veldhuisen, Anouk E.J. Latenstein, Helga Blauw, Lyan B. Vlaskamp, Michel Klaassen, Daan J. Lips, Bert A. Bonsing, Erwin van der Harst, Martijn W.J. Stommel, Marco J. Bruno et al. · 2022 · JAMA Surgery
36. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID‐19: A continuous glucose monitoring‐based observational study
    Xiumei Wu, Sihui Luo, Xueying Zheng, Yu Ding, Siqi Wang, Ping Ling, Tong Yue, Wen Xu, Jinhua Yan, Jianping Weng · 2021 · Journal of Diabetes Investigation
37. Digital health: current applications, challenges, and future directions for enhancing healthcare quality and safety
    Saidi Hu, Danyang Song, Siran Wan, Shunhong Zhang, Chenchen Luo, Nian Li, Guangyue Liu, Jailson da Graça Espírito Santo Vasconcelos, Leonilde Lavres Ceita de Carvalho, Eveline Neobísi et al. · 2025 · Frontiers in Public Health
38. Alarm Settings of Continuous Glucose Monitoring Systems and Associations to Glucose Outcomes in Type 1 Diabetes
    Yu Kuei Lin, Danielle Groat, Owen T. M. Chan, Man Hung, Anu Rani Sharma, Michael Walter Varner, Ramkiran Gouripeddi, Julio Cesar Facelli, Simon J. Fisher · 2019 · Journal of the Endocrine Society
39. Type 1 Diabetes and Physical Exercise: Moving (forward) as an Adjuvant Therapy
    Othmar Moser, Max Lennart Eckstein, Daniel J. West, Nandu Goswami, Harald Sourij, Peter Hofmann · 2020 · Current Pharmaceutical Design
40. Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
    Ralph Ziegler, Lutz Heinemann, Guido Freckmann, Oliver Schnell, Rolf Hinzmann, Bernd Kulzer · 2020 · Journal of Diabetes Science and Technology
41. Continuous glucose monitoring in subjects undergoing bariatric surgery: Diurnal and nocturnal glycemic patterns
    Roberta Lupoli, Erminia Lembo, Paola Ciciola, Luigi Schiavo, Vincenzo Pilone, Brunella Capaldo · 2020 · Nutrition Metabolism and Cardiovascular Diseases
42. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study
    Sara Charleer, Christophe E.M. De Block, Frank R. E. Nobels, Régis Pierre Radermecker, Ine Lowyck, Annelies Mullens, Denis Scarnière, Katrien Spincemaille, Marie Strivay, Eric Weber et al. · 2020 · Diabetes Care
43. Comparison of glycemic metrics measured simultaneously by intermittently scanned continuous glucose monitoring and real-time continuous glucose monitoring in pregnant women with type 1 diabetes
    Nørgaard, Sidse Kjærhus, Mathiesen, Elisabeth Reinhardt, Nørgaard, Kirsten, Ringholm, Lene · 2021 · Diabetes Technology & Therapeutics
44. Solutions to Address Inequity in Diabetes Technology Use in Type 1 Diabetes: Results from Multidisciplinary Stakeholder Co-creation Workshops
    Shivani Agarwal, Gladys Crespo-Ramos, Stephanie L. Leung, MOLLY FINNAN, Tina Park, Katie McCurdy, Jeffrey S. Gonzalez, Judith A. Long · 2022 · Diabetes Technology & Therapeutics
45. Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study
    Patrick Divilly, Gilberte Martine‐Edith, Natalie Zaremba, Uffe Søholm, ZEINAB MAHMOUDI, Monika Cigler, Namam Ali, Evertine J. Abbink, Julie Maria Bøggild Brøsen, Bastiaan E. de Galan et al. · 2024 · Diabetes Care
46. Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies
    Medha N. Munshi, Anna R. Kahkoska, Joshua J. Neumiller, Anastasia‐Stefania Alexopoulos, Nancy A. Allen, Tali Cukierman‐Yaffe, Elbert S. Huang, Sei J. Lee, Kasia J. Lipska, Lisa M. McCarthy et al. · 2025 · The Lancet Diabetes & Endocrinology
47. Going beyond HbA1c to understand the benefits of advanced diabetes therapies
    Robert Alan Vigersky · 2018 · Journal of Diabetes
48. Associations Between the Time in Hypoglycemia and Hypoglycemia Awareness Status in Type 1 Diabetes Patients Using Continuous Glucose Monitoring Systems
    Yu Kuei Lin, Danielle Groat, Owen T. M. Chan, Man Hung, Anu Rani Sharma, Michael Walter Varner, Ramkiran Gouripeddi, Julio Cesar Facelli, Simon J. Fisher · 2020 · Diabetes Technology & Therapeutics
49. Impact of Hybrid Closed Loop Therapy on Hypoglycemia Awareness in Individuals with Type 1 Diabetes and Impaired Hypoglycemia Awareness
    Marie‐Anne Burckhardt, Mary Binsu Abraham, Julie Dart, Grant J. Smith, Nirubasini Paramalingam, Joanne M. O’Dea, Martin I. de Bock, Elizabeth Ann Davis, Timothy William Jones · 2021 · Diabetes Technology & Therapeutics
50. Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe
    Andrej Janež, Tadej Battelino, Tomasz Klupa, Győző Kocsis, M Kuricova, Nebojsa M. Lalic, Anca Pantea Stoian, Martin Prázný, Dario Rahelić, Jan Šoupal et al. · 2021 · Diabetes Therapy
51. Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessment
    Vanita R. Aroda, Robert H. Eckel · 2022 · Diabetes Obesity and Metabolism
52. Examining the Relationship Between Pre- and Postprandial Glucose Levels and Insulin Bolus Timing Using Bluetooth-Enabled Insulin Pen Cap Technology and Continuous Glucose Monitoring
    Toschi, Elena, Slyne, Christine, Greenberg, Jordan M., Greaves, Tori, Atakov-Castillo, Astrid, Carl, Sam, Dufour, Alyssa B., Munshi, Medha · 2020 · Diabetes Technology & Therapeutics
53. Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index
    Lalantha Leelarathna, Hood Thabit, Malgorzata E. Wilinska, Lia Bally, Julia Katharina Mader, Thomas Rudolf Pieber, Carsten Benesch, Sabine Arnolds, Terri Kang Johnson, Lutz Heinemann et al. · 2019 · Journal of Diabetes Science and Technology
54. Time-in-range as a target in type 2 diabetes: An urgent need
    Banshi Saboo, Jothydev Kesavadev, Arun Shankar, Meera B. Krishna, Shruti Sheth, Vidisha Patel, Gopika Krishnan · 2021 · Heliyon
55. Monitoring Lipolysis by Sensing Breath Acetone down to Parts‐per‐Billion
    Ines C. Weber, Nina Derron, Karsten Königstein, Philipp A. Gerber, Andreas T. Güntner, Sotiris E. Pratsinis · 2021 · Small Science
56. Leveraging advances in diabetes technologies in primary care: a narrative review
    Bruce W. Bode, Aaron King, David L Russell-Jones, Liana K. Billings · 2021 · Annals of Medicine
57. Continuous Glucose Monitoring in Adolescents With Obesity: Monitoring of Glucose Profiles, Glycemic Excursions, and Adherence to Time Restricted Eating Programs
    Monica N. Naguib, Elizabeth Hegedus, Jennifer K. Raymond, Michael I. Goran, Sarah‐Jeanne Salvy, Choo Phei Wee, Ramón Durazo-Arvizú, Lilith Moss, Alaina P. Vidmar · 2022 · Frontiers in Endocrinology
58. Semi-Implantable Bioelectronics
    Jiaru Fang, Shuang Huang, Fanmao Liu, Gen He, Xiangling Li, Xinshuo Huang, Hui‐Jiuan Chen, Xi Xie · 2022 · Nano-Micro Letters
59. Clinical application guidelines for blood glucose monitoring in China (2022 edition)
    Yuqian Bao, Dalong Zhu, Chinese Diabetes Society · 2022 · Diabetes/Metabolism Research and Reviews
60. How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with type 1 diabetes?
    Livingstone, R., Boyle, J. G., Petrie, J. R. · 2020 · Diabetic Medicine
61. Plant-Based Meat Analogs and Their Effects on Cardiometabolic Health: An 8-Week Randomized Controlled Trial Comparing Plant-Based Meat Analogs With Their Corresponding Animal-Based Foods
    Darel Wee Kiat Toh, Amanda Simin Fu, Kervyn Ajay Mehta, Nicole Yi Lin Lam, Sumanto Haldar, Christiani Jeyakumar Henry · 2024 · American Journal of Clinical Nutrition
62. From Stability to Variability: Classification of Healthy Individuals, Prediabetes, and Type 2 Diabetes Using Glycemic Variability Indices from Continuous Glucose Monitoring Data
    Simon Lebech Cichosz, Thomas Kronborg, Esben Laugesen, Stine Hangaard, Jesper Fleischer, Troels Krarup Hansen, Morten Hasselstrøm Jensen, Per Løgstrup Poulsen, Peter Vestergaard · 2024 · Diabetes Technology & Therapeutics
63. Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA 1c in individuals with and without diabetes
    Kristine Færch, Marjan Alssema, David J. Mela, Rikke Borg, Dorte Vistisen · 2018 · Nutrition and Diabetes
64. Diagnosis, Therapy and Follow-up of Diabetes Mellitus in Children and Adolescents
    Andreas Neu, Jutta Bürger-Büsing, Thomas Danne, Axel Dost, Martin Holder, Reinhard Walter Holl, Paul‐Martin Holterhus, Thomas Michael Kapellen, Beate Karges, Olga Kordonouri et al. · 2019 · Experimental and Clinical Endocrinology & Diabetes
65. Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality
    Michael P. Bancks, April P. Carson, Cora Elizabeth Lewis, Erica P. Gunderson, Jared P. Reis, Pamela J. Schreiner, Yuichiro Yano, Mercedes R. Carnethon · 2019 · Diabetologia
66. Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations
    J.L. Leahy, Grazia Aleppo, Vivian Andrew Fonseca, Satish K. Garg, Irl B. Hirsch, Anthony L. McCall, Janet B. McGill, William H. Polonsky · 2019 · Journal of the Endocrine Society
67. CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes
    Mercedes J. Burnside, Dana Michelle Lewis, Hamish R. Crocket, R. Wilson, Jonathan A. Williman, Craig Jefferies, Ryan G. Paul, Benjamin John Wheeler, Martin I. de Bock · 2020 · Journal of Diabetes & Metabolic Disorders
68. Glucose variability and mood in adults with diabetes: A systematic review
    Linda T. Muijs, Caterina Racca, Maartje de Wit, Annelies Brouwer, Thomas H. Wieringa, Ralph de Vries, Erik H. Serné, Daniël H. van Raalte, Femke Rutters, Frank Jan Snoek · 2020 · Endocrinology Diabetes & Metabolism
69. Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes
    Yifei Mo, Xiaojing Ma, Jingyi Lu, Yun Shen, Yufei Wang, Lei Zhang, Wei Lu, Wei Zhu, Yuqian Bao, Jian Zhou · 2020 · Journal of Diabetes Investigation
70. Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies
    M. Garofolo, M. Aragona, Cosimo Rodia, P. Falcetta, A. Bertolotto, F. Campi, S. Del Prato, G. Penno · 2021 · Diabetes Research and Clinical Practice
71. Improved Glycemic Control Observed in Children with Type 1 Diabetes Following the Introduction of Smart Insulin Pens: A Real-World Study
    Peter Adolfsson, Viktor Björnsson, Niels Væver Hartvig, Anne Kaas, Jonas Bech Møller, Elsa Ogionwo Lange · 2021 · Diabetes Therapy
72. The changing landscape of automated insulin delivery in the management of type 1 diabetes
    Rama Lakshman, Charlotte K. Boughton, Roman Hovorka · 2023 · Endocrine Connections
73. Generalization of a Deep Learning Model for Continuous Glucose Monitoring–Based Hypoglycemia Prediction: Algorithm Development and Validation Study
    Jian Shao, Ziqing Liu, Shaoyun Li, Huyi Feng, Jingzhen Li, Zedong Nie, Ying Pan, Huyi Feng, Yuefei Li, Lin Yang et al. · 2024 · JMIR Medical Informatics
74. The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular Complications
    Boris P. Kovatchev, Benjamin J. Lobo, Chiara Fabris, Mohammadreza Ganji, Anas El Fathi, Marc D. Breton, Lauren G. Kanapka, Craig Kollman, Tadej Battelino, Roy W. Beck · 2025 · Diabetes Technology & Therapeutics
75. Predicting Nocturnal Hypoglycemia from Continuous Glucose Monitoring Data with Extended Prediction Horizon.
    Long Vu, Sarah Kefayati, Tsuyoshi Idé, Venkata N. Pavuluri, Gretchen Purcell Jackson, Lisa Latts, Yuxiang Zhong, Pratik K. Agrawal, Yuan‐Chi Chang · 2019 · PubMed Central
76. Adherence to Personal Health Devices
    Sudip Vhaduri, Temiloluwa Prioleau · 2020 · International Conference on Pervasive Computing Technologies for Healthcare
77. Ambulatory Glucose Profile (AGP) Report in Daily Care of Patients with Diabetes: Practical Tips and Recommendations
    Leszek Czupryniak, Grzegorz Jan Dzida, Piotr Fichna, Przemysława A. Jarosz-Chobot, Janusz Gumprecht, Tomasz Klupa, Małgorzata Myśliwiec, Agnieszka Szadkowska, Dorota Agata Bomba-Opon, Krzysztof Czajkowski et al. · 2022 · Diabetes Therapy
78. One‐year real‐world performance of the DBLG1 closed‐loop system: Data from 3706 adult users with type 1 diabetes in Germany
    Benhamou, Pierre‐Yves, Adenis, Alice, Lebbad, Hocine, Tourki, Yousra, Heredia, Maria‐Belen, Gehr, Bernhard, Franc, Sylvia, Charpentier, Guillaume · 2023 · Diabetes, Obesity and Metabolism
79. Hypo‐METRICS: Hypoglycaemia—MEasurement, ThResholds and ImpaCtS—A multi‐country clinical study to define the optimal threshold and duration of sensor‐detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol
    Patrick Divilly, Natalie Zaremba, ZEINAB MAHMOUDI, Uffe Søholm, Daniel John Pollard, Melanie M Broadley, Evertine J. Abbink, Bastiaan E. de Galan, Ulrik Pedersen‐Bjergaard, Éric Renard et al. · 2022 · Diabetic Medicine
80. Oral Microbiota in Children and Adolescents with Type 1 Diabetes Mellitus: Novel Insights into the Pathogenesis of Dental and Periodontal Disease
    Maria Carelli, Alice Maguolo, Chiara Zusi, Francesca Olivieri, Federica Emiliani, Gelinda De Grandi, Ilaria Unali, Nicoletta Zerman, Caterina Signoretto, Claudio Maffeis · 2023 · Microorganisms
81. Non-adjunctive flash glucose monitoring system use during summer-camp in children with type 1 diabetes: The free-summer study
    Claudia Anita Piona, Klemen Dovč, Gül Yeşiltepe Mutlu, Klara Grad, Petra Gregorc, Tadej Battelino, Nataša Bratina · 2018 · Pediatric Diabetes
82. Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning
    Michael Mayo, Lynne M. Chepulis, Ryan G. Paul · 2019 · PLoS ONE
83. Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics
    Stefan Pleus, Ulrike Kamecke, Delia Waldenmaier, Manuela Link, Eva Zschornack, Nina R. M. Jendrike, Cornelia Haug, Guido Freckmann · 2020 · Journal of Diabetes Science and Technology
84. Fasting May Alter Blood Glucose Responses to High-Intensity Interval Exercise in Adults With Type 1 Diabetes: A Randomized, Acute Crossover Study
    Jane Elizabeth Yardley · 2020 · Canadian Journal of Diabetes
85. Advances in Exercise, Physical Activity, and Diabetes Mellitus
    Trevor Teich, Dessi P. Zaharieva, Michael Charles Riddell · 2019 · Diabetes Technology & Therapeutics
86. Continuous glucose monitoring use and glucose variability in pre-school children with type 1 diabetes
    Klemen Dovč, Kevin Cargnelutti, Anze Sturm, Julij Šelb, Nataša Bratina, Tadej Battelino · 2018 · Diabetes Research and Clinical Practice
87. Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial
    Reznik, Yves, Carvalho, Martin, Fendri, Salha, Prevost, Gaetan, Chaillous, Lucy, Riveline, Jean Pierre, Hanaire, Hélène, Dubois, Séverine, Houéto, Patrick, Pasche, Hélène et al. · 2024 · Diabetes, Obesity and Metabolism
88. Smart Pen Exposes Missed Basal Insulin Injections and Reveals the Impact on Glycemic Control in Adults With Type 1 Diabetes
    Ekberg, Neda Rajamand, Hartvig, Niels Væver, Kaas, Anne, Møller, Jonas Bech, Adolfsson, Peter · 2024 · Journal of Diabetes Science and Technology
89. Key indices of glycaemic variability for application in diabetes clinical practice
    Louis Monnier, Fabrice Bonnet, C Colette, Éric Renard, David R. Owens · 2023 · Diabetes & Metabolism
90. The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app
    Uffe Søholm, Melanie M Broadley, Natalie Zaremba, Patrick Divilly, Petra Martina Baumann, ZEINAB MAHMOUDI, Gilberte Martine‐Edith, Julia Katharina Mader, Monika Cigler, Julie Maria Bøggild Brøsen et al. · 2024 · Diabetologia
91. GlyCulator2: an update on a web application for calculation of glycemic variability indices
    Konrad Pagacz, Konrad Stawiski, Agnieszka Szadkowska, Wojciech Michal Mlynarski, Wojciech M Fendler · 2018 · Acta Diabetologica
92. Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes
    Merete Bechmann Christensen, Peter Gæde, Eva Elisabeth Hommel, Anders Gotfredsen, Kirsten Nørgaard · 2019 · Diabetes & Metabolism
93. Real-world flash glucose monitoring in Brazil: can sensors make a difference in diabetes management in developing countries?
    Luís Eduardo Calliari, Márcio Krakauer, André Gustavo Daher Vianna, Yashesvini Ram, Douglas Eugenio Barbieri, Yongjin Xu, Timothy C. Dunn · 2020 · Diabetology & Metabolic Syndrome
94. Comparison of two advanced hybrid closed loop in a pediatric population with type 1 diabetes: a real-life observational study
    Riccardo Schiaffini, Annalisa Deodati, M. C. Nicoletti, Chiara Carducci, Paolo Ciampalini, Antonella Lorubbio, Maria Cristina Matteoli, Valentina Pampanini, Ippolita Patrizia Patera, Novella Rapini et al. · 2022 · Acta Diabetologica
95. Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 System
    Pierre‐Yves Benhamou, Alice Adenis, Yousra Tourki, Sylvie Pou, Stéphanie Madrolle, Sylvia Franc, Dulanjalee Kariyawasam, Jacques Beltrand, David Charles Klonoff, Guillaume Charpentier · 2022 · Journal of Diabetes Science and Technology
96. Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial
    Mercedes J. Burnside, Dana Michelle Lewis, Hamish R. Crocket, Renee A. Meier, Jonathan A. Williman, Olivia J. Sanders, Craig Jefferies, Ann M. Faherty, Ryan G. Paul, Claire S. Lever et al. · 2023 · Diabetes Technology & Therapeutics
97. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes
    Rivera-Ávila, Dulce Adelaida, Esquivel-Lu, Alejandro Iván, Salazar-Lozano, Carlos Rafael, Jones, Kyla, Doubova, Svetlana V. · 2021 · BMC Endocrine Disorders
98. Improved HbA1c and reduced glycaemic variability after 1-year intermittent use of flash glucose monitoring
    Zhang, Wenhui, Liu, Yu, Sun, Baosheng, Shen, Yanjun, Li, Ming, Peng, Lanbo, Duan, Honggang, Su, Xudong, Lu, Shaoxia, Tian, Xiaoqin et al. · 2021 · Scientific Reports
99. Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel
    Sanjay Kalra, Shehla Sajid Shaikh, Gagan Priya, ManasP Baruah, Abhyudaya Verma, Ashok Kumar Das, Mona Shah, Sambit Das, Deepak Khandelwal, Debmalya Sanyal et al. · 2020 · Diabetes Therapy
100. Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections
     Špela Volčanšek, Mojca Lunder, Andrej Janež · 2019 · Diabetes Technology & Therapeutics